Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
-1.png)
Devyser secures SEK 8.9M five-year tender and strengthens Italian position
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Noninvasive fetal RHD testing is emerging as a standard of care: insights from a global survey
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
A workflow the team trusts: Several years of routine CFTR testing in a reproductive genetics lab in Germany
For many laboratories, CFTR testing is not an occasional add-on. It is part of a routine,...